Formamide Detected in Multiple Diaper Brands Sparks Safety Crisis and Regulatory Gaps

In mid-June 2024, investigations revealed that major infant diaper brands including Huggies, Babycare, and Babisil contained formamide, a toxic chemical classified by the European Union as a Category 1B reproductive hazard. Multiple testing laboratories confirmed the substance's presence through advanced testing methods simulating the warm, enclosed environment of diaper use. More alarmingly, formamide was subsequently detected in blood and urine samples from numerous infants undergoing clinical screening at Shandong Province's Public Health Clinical Center, confirming real-world exposure. One journalist who wore a contaminated diaper overnight experienced nearly a doubling of formamide concentration in their blood, providing further evidence of the chemical's skin penetration and systemic absorption.

The contamination triggered widespread consumer concern, with parents reporting repeated cases of diaper rash, skin breakdown, and inflammation in infants using affected products—symptoms that resolved upon discontinuation and recurred upon reuse. These clinical observations aligned with toxicological evidence: formamide, an industrial solvent, can penetrate skin barriers and accumulate in the human body, posing particular risks to infants whose developing organs and metabolic systems are far less capable of processing toxins than adults. Exposure poses documented risks including reproductive system developmental damage, chronic liver and kidney injury, and teratogenic effects, especially in vulnerable populations including pregnant women and infants.

When confronted, all implicated manufacturers responded with identical justifications: products comply with national standards. This uniform defense exposed a critical regulatory blind spot. China's current national standard for infant diapers (GB/T 28004.1—2021) is a recommendation rather than mandatory requirement and contains no testing parameters or maximum limits for formamide. Under this standard framework, manufacturers can legally sell products containing the chemical, as no exceedance of non-existent limits can occur. Although formamide is already banned in China's cosmetics prohibited ingredients list, diapers fall outside that regulatory scope, creating an unintended loophole.

Legal experts and analysts emphasized that compliance with national standards does not absolve manufacturers of liability under China's Product Quality Law, which requires that products "not contain unreasonable dangers to personal safety or property." Parents purchasing diapers reasonably expect products will not harm their infants' health; if documented exposure causes demonstrable injury, manufacturers remain legally responsible regardless of standards compliance. However, without specific formamide limits in the diaper standard, regulators lack direct regulatory grounds to declare products non-compliant, complicating enforcement and consumer remedies.

The incident exposed systemic vulnerabilities in infant product governance and triggered urgent calls for regulatory reform. Experts and commentators recommend that authorities immediately initiate comprehensive revision of diaper standards to include formamide and other known toxic substances in mandatory testing requirements with established safety limits. Industry analysts noted that for foreign brands like Huggies, the revelation devastates years of brand positioning around safety and care; for domestic competitors like Babycare and Babisil, the crisis threatens nascent consumer trust in Chinese-made mother-and-baby products. Both categories face reputational collapse and potential market share loss as parents reassess product safety.

The case underscores a fundamental tension in regulatory policy: standards typically respond to identified hazards only after harm occurs, yet the absence of proactive standards allows known toxins to circulate freely in high-contact consumer goods. Authorities called for accelerated standard-setting processes, transparency in independent testing, and, for affected companies, voluntary disclosure of test data and initiation of product recalls. As one analyst concluded, when a infant's skin breakdown becomes the primary mechanism for identifying product dangers, and when confirmed reproductive toxins legally circulate due to regulatory gaps, the entire industry's trust foundation has eroded.